{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:36:21Z","timestamp":1791146181354,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["A93022"],"award-info":[{"award-number":["A93022"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C602\/A11359"],"award-info":[{"award-number":["C602\/A11359"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5255\/A16466"],"award-info":[{"award-number":["C5255\/A16466"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bcp.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T01:33:11Z","timestamp":1410831191000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Glycogen metabolism in cancer"],"prefix":"10.1016","volume":"92","author":[{"given":"Christos E.","family":"Zois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Favaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.09.001_bib0005","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/jcbfm.2010.151","article-title":"Glycogenolysis in astrocytes supports blood-borne glucose channeling not glycogen-derived lactate shuttling to neurons: evidence from mathematical modeling","volume":"30","author":"DiNuzzo","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/jcbfm.2014.33","article-title":"Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia","volume":"34","author":"Saez","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2009.08.013","article-title":"Stranger in a strange land: roles of glycogen turnover in adipose tissue metabolism","volume":"318","author":"Markan","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0020","first-page":"1165","article-title":"Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins","volume":"41","author":"Rousset","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.09.001_bib0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s005350050299","article-title":"Estimation of glycogen levels in human colorectal cancer tissue: relationship with cell cycle and tumor outgrowth","volume":"34","author":"Takahashi","year":"1999","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0030","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1096\/fasebj.3.11.2673899","article-title":"Indirect versus direct routes of hepatic glycogen synthesis","volume":"3","author":"Kurland","year":"1989","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0035","series-title":"Biochemistry","author":"Berg","year":"2002"},{"key":"10.1016\/j.bcp.2014.09.001_bib0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BJ20111416","article-title":"Glycogen and its metabolism: some new developments and old themes","volume":"441","author":"Roach","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cmet.2011.04.004","article-title":"Autophagy in the cellular energetic balance","volume":"13","author":"Singh","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.prp.2006.04.001","article-title":"Glycogen autophagy in glucose homeostasis","volume":"202","author":"Kotoulas","year":"2006","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.bcp.2014.09.001_bib0055","doi-asserted-by":"crossref","first-page":"34960","DOI":"10.1074\/jbc.M110.150839","article-title":"Starch binding domain-containing protein 1\/genethonin 1 is a novel participant in glycogen metabolism","volume":"285","author":"Jiang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0060","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2011.08.106","article-title":"Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1","volume":"413","author":"Jiang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2014.09.001_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-5956-11-11","article-title":"The 3T3-L1 adipocyte glycogen proteome","volume":"11","author":"Stapleton","year":"2013","journal-title":"Proteome Sci"},{"key":"10.1016\/j.bcp.2014.09.001_bib0070","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/pmic.200900628","article-title":"Analysis of hepatic glycogen-associated proteins","volume":"10","author":"Stapleton","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.bcp.2014.09.001_bib0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0040-8166(96)80013-9","article-title":"Glycosomes \u2013 the organelles of glycogen metabolism","volume":"28","author":"Rybicka","year":"1996","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bcp.2014.09.001_bib0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/emmm.201200241","article-title":"Deleterious effects of neuronal accumulation of glycogen in flies and mice","volume":"4","author":"Duran","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bcp.2014.09.001_bib0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1742-4658.2012.08549.x","article-title":"Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii","volume":"280","author":"Gentry","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0090","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/hmg\/ddu024","article-title":"Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease","volume":"23","author":"Duran","year":"2014","journal-title":"Human Mol Genet"},{"key":"10.1016\/j.bcp.2014.09.001_bib0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/13543776.2013.794790","article-title":"Glycogen phosphorylase inhibitors: a patent review (2008\u20132012)","volume":"23","author":"Gaboriaud-Kolar","year":"2013","journal-title":"Expert Opin Ther Patents"},{"key":"10.1016\/j.bcp.2014.09.001_bib0100","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2174\/1389557511009011175","article-title":"Physiological control of liver glycogen metabolism: lessons from novel glycogen phosphorylase inhibitors","volume":"10","author":"Agius","year":"2010","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2174\/1389557511009011139","article-title":"Recent advances in the allosteric inhibition of glycogen phosphorylase","volume":"10","author":"Loughlin","year":"2010","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.beem.2007.09.001","article-title":"New hepatic targets for glycaemic control in diabetes","volume":"21","author":"Agius","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0115","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1074\/jbc.M808576200","article-title":"Control of liver glycogen synthase activity and intracellular distribution by phosphorylation","volume":"284","author":"Ros","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(03)00565-9","article-title":"Control of glycogen deposition","volume":"546","author":"Ferrer","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0125","doi-asserted-by":"crossref","first-page":"9740","DOI":"10.1074\/jbc.M212151200","article-title":"Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase","volume":"278","author":"Gomis","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0130","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1742-4658.2005.04585.x","article-title":"A novel glycogen-targeting subunit of protein phosphatase 1 that is regulated by insulin and shows differential tissue distribution in humans and rodents","volume":"272","author":"Munro","year":"2005","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0014-5793(95)01184-G","article-title":"Amino acid sequence and expression of the hepatic glycogen-binding (GL)-subunit of protein phosphatase-1","volume":"375","author":"Doherty","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0140","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2337\/diabetes.50.4.720","article-title":"Control of glycogen synthesis by glucose, glycogen, and insulin in cultured human muscle cells","volume":"50","author":"Halse","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2014.09.001_bib0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cmet.2010.10.006","article-title":"Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle","volume":"12","author":"Bouskila","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0150","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1016\/j.febslet.2010.09.040","article-title":"Hypoxia-inducible factor 1-mediated regulation of PPP1R3C promotes glycogen accumulation in human MCF-7 cells under hypoxia","volume":"584","author":"Shen","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/emmm.201100193","article-title":"Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress","volume":"4","author":"Cheng","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bcp.2014.09.001_bib0160","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","article-title":"MYC-induced cancer cell energy metabolism and therapeutic opportunities","volume":"15","author":"Dang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2014.09.001_bib0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","article-title":"Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy","volume":"273","author":"Luo","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1024980710799","article-title":"Mechanism of glycogen supercompensation in rat skeletal muscle cultures","volume":"250","author":"Mamedova","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fonc.2012.00018","article-title":"Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival","volume":"2","author":"Pelletier","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0180","doi-asserted-by":"crossref","first-page":"e9644","DOI":"10.1371\/journal.pone.0009644","article-title":"Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1","volume":"5","author":"Pescador","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2014.09.001_bib0185","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1027302021428","article-title":"Glycogen metabolism in rat heart muscle cultures after hypoxia","volume":"254","author":"Vigoda","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cmet.2012.10.017","article-title":"Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells","volume":"16","author":"Favaro","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0195","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M901790200","article-title":"Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts","volume":"284","author":"Mole","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0200","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/cncr.24232","article-title":"Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein","volume":"115","author":"Kaelin","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2014.09.001_bib0205","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/onc.2011.594","article-title":"Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish","volume":"31","author":"Camus","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2014.09.001_bib0210","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/sj.bjc.6602243","article-title":"Metabolic sensitivity of pancreatic tumour cell apoptosis to glycogen phosphorylase inhibitor treatment","volume":"91","author":"Lee","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2014.09.001_bib0215","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MPA.0b013e318236f022","article-title":"Inhibition of glycogen phosphorylation induces changes in cellular proteome and signaling pathways in MIA pancreatic cancer cells","volume":"41","author":"Ma","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.bcp.2014.09.001_bib0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmet.2008.11.008","article-title":"The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor","volume":"9","author":"McBride","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0225","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1083\/jcb.8.3.575","article-title":"Identification of glycogen in electron micrographs of thin tissue sections","volume":"8","author":"Revel","year":"1960","journal-title":"J Biophys Biochem Cytol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10520294809106232","article-title":"Histological and histochemical uses of periodic acid","volume":"23","author":"Mc","year":"1948","journal-title":"Stain Technol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0235","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1074\/jbc.M706334200","article-title":"Hepatic glycogen synthesis in the absence of glucokinase: the case of embryonic liver","volume":"283","author":"Cifuentes","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0240","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1111\/j.1742-4658.2011.08287.x","article-title":"Increased glucose concentration results in reduced proteasomal activity and the formation of glycogen positive aggresomal structures","volume":"278","author":"Puri","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0245","doi-asserted-by":"crossref","first-page":"e77774","DOI":"10.1371\/journal.pone.0077774","article-title":"An optimized histochemical method to assess skeletal muscle glycogen and lipid stores reveals two metabolically distinct populations of type I muscle fibers","volume":"8","author":"Prats","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2014.09.001_bib0250","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5357\/koubyou.60.264","article-title":"Production of monoclonal antibody that recognizes glycogen and its application for immunohistochemistry","volume":"60","author":"Baba","year":"1993","journal-title":"Kokubyo Gakkai Zasshi"},{"key":"10.1016\/j.bcp.2014.09.001_bib0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/01913123.2011.601404","article-title":"Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment","volume":"35","author":"Hicks","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0260","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0003-2697(74)90248-6","article-title":"A comparison of three methods of glycogen measurement in tissues","volume":"60","author":"Passonneau","year":"1974","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0265","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10719-007-9075-7","article-title":"Fluorescent glycogen formation with sensibility for in vivo and in vitro detection","volume":"25","author":"Louzao","year":"2008","journal-title":"Glycoconj J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0270","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1158\/0008-5472.CAN-13-2768","article-title":"A novel radiotracer to image glycogen metabolism in tumors by positron emission tomography","volume":"74","author":"Witney","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.09.001_bib0275","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.09.001_bib0280","first-page":"381029","article-title":"Small-molecule inhibitors of GSK-3: structural insights and their application to Alzheimer's disease models","volume":"2012","author":"Kramer","year":"2012","journal-title":"Int J Alzheimer's Dis"},{"key":"10.1016\/j.bcp.2014.09.001_bib0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2013.04.022","article-title":"Activator or inhibitor? GSK-3 as a new drug target","volume":"86","author":"Takahashi-Yanaga","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0290","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.2174\/1381612811319260007","article-title":"Design of glycogen synthase kinase-3 inhibitors: an overview on recent advancements","volume":"19","author":"Arfeen","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bcp.2014.09.001_bib0295","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/10409238.2010.488215","article-title":"AMPK inhibition in health and disease","volume":"45","author":"Viollet","year":"2010","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diabetes.52.1.9","article-title":"Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase","volume":"52","author":"Halse","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2014.09.001_bib0305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.molcel.2013.03.022","article-title":"Inhibition of AMPK catabolic action by GSK3","volume":"50","author":"Suzuki","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2014.09.001_bib0310","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1517\/13543776.2012.743994","article-title":"Direct AMP-activated protein kinase activators: a review of evidence from the patent literature","volume":"22","author":"Giordanetto","year":"2012","journal-title":"Expert Opin Ther Patents"},{"key":"10.1016\/j.bcp.2014.09.001_bib0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.09.001_bib0320","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2014.09.001_bib0325","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrc3801","article-title":"Cachexia: running on empty","volume":"14","author":"McCarthy","year":"2014","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.bcp.2014.09.001_bib0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1517\/13543784.10.3.439","article-title":"Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus","volume":"10","author":"Treadway","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bcp.2014.09.001_bib0335","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612033454919","article-title":"Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments","volume":"9","author":"Somsak","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bcp.2014.09.001_bib0340","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2174\/1389557043403459","article-title":"Intervention of hepatic glucose production. Small molecule regulators of potential targets for Type 2 diabetes therapy","volume":"4","author":"Barf","year":"2004","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0345","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2174\/138955706777934991","article-title":"Glycogen phosphorylase inhibitors","volume":"6","author":"Henke","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0350","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.2174\/092986708786848659","article-title":"New inhibitors of glycogen phosphorylase as potential antidiabetic agents","volume":"15","author":"Somsak","year":"2008","journal-title":"Curr Med Chem"},{"issue":"Pt 3","key":"10.1016\/j.bcp.2014.09.001_bib0355","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bj3420545","article-title":"Inhibition of glycogenolysis in primary rat hepatocytes by 1,4-dideoxy-1,4-imino-d-arabinitol","volume":"342","author":"Andersen","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0360","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0968-0896(00)00291-1","article-title":"Iminosugars: potential inhibitors of liver glycogen phosphorylase","volume":"9","author":"Jakobsen","year":"2001","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0365","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/bj20021070","article-title":"Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes","volume":"368","author":"Latsis","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2014.09.001_bib0370","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2337\/diabetes.49.9.1419","article-title":"Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite","volume":"49","author":"Bergans","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2014.09.001_bib0375","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1021\/jm031121n","article-title":"Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site","volume":"47","author":"Kristiansen","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0380","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1016\/j.bmcl.2003.08.046","article-title":"A new class of glycogen phosphorylase inhibitors","volume":"13","author":"Lu","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0385","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/jm049034y","article-title":"Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes","volume":"48","author":"Klabunde","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0390","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1110\/ps.051432405","article-title":"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs","volume":"14","author":"Oikonomakos","year":"2005","journal-title":"Protein Sci"},{"key":"10.1016\/j.bcp.2014.09.001_bib0395","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1073\/pnas.95.4.1776","article-title":"Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo","volume":"95","author":"Martin","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2014.09.001_bib0400","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1021\/jm980264k","article-title":"Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase","volume":"41","author":"Hoover","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0405","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1097-2765(05)00006-7","article-title":"Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core","volume":"6","author":"Rath","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2014.09.001_bib0410","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-5521(00)00004-1","article-title":"Human liver glycogen phosphorylase inhibitors bind at a new allosteric site","volume":"7","author":"Rath","year":"2000","journal-title":"Chem Biol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0415","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0969-2126(00)00144-1","article-title":"A new allosteric site in glycogen phosphorylase b as a target for drug interactions","volume":"8","author":"Oikonomakos","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2014.09.001_bib0420","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/j.bmcl.2003.09.022","article-title":"Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a","volume":"13","author":"Rosauer","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0425","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1016\/j.bmcl.2006.08.047","article-title":"Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies","volume":"16","author":"Whittamore","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0430","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bmcl.2006.10.037","article-title":"Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors","volume":"17","author":"Birch","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2014.09.001_bib0435","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0706925","article-title":"Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme","volume":"149","author":"Freeman","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.09.001_bib0440","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/abbi.2000.2220","article-title":"The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase","volume":"386","author":"Kaiser","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bcp.2014.09.001_bib0445","doi-asserted-by":"crossref","first-page":"34566","DOI":"10.1074\/jbc.M004485200","article-title":"Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site","volume":"275","author":"Oikonomakos","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0450","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1016\/j.bmc.2006.07.060","article-title":"Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site","volume":"14","author":"Hampson","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bcp.2014.09.001_bib0455","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu Rev Cell Dev Biol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214005255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214005255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:59:19Z","timestamp":1777377559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214005255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0006295214005255"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.09.001","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycogen metabolism in cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}